Bibliography

Found 21 results

Filters: Author is Scott Letendre and Keyword is Female [Clear All Filters]

Journal Article

Clifford DB, Vaida F, Kao Y-ting, Franklin D, Letendre S, Collier AC, Marra CM, Gelman B, McArthur JC, Morgello S, et al. Absence of neurocognitive effect of hepatitis C infection in HIV-coinfected people. Neurology. 2015 ;84(3):241-50.

Morgan EE, Woods SPaul, Letendre S, Franklin D, Bloss C, Goate A, Heaton RK, Collier AC, Marra CM, Gelman B, et al. Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders. J Neurovirol. 2013 ;19(2):150-6.

Perez-Valero I, Ellis RJ, Heaton RK, Deutsch R, Franklin D, Clifford DB, Collier AC, Gelman B, Marra C, McCutchan JA, et al. Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects. AIDS. 2019 ;33(3):475-481.

Marcotte TD, Deutsch R, Michael BDaniel, Franklin D, Cookson DRosario, Bharti AR, Grant I, Letendre S. A concise panel of biomarkers identifies neurocognitive functioning changes in HIV-infected individuals. J Neuroimmune Pharmacol. 2013 ;8(5):1123-35.

Sakamoto M, Marcotte TD, Umlauf A, Franklin D, Heaton RK, Ellis RJ, Letendre S, Alexander T, McCutchan JA, Morgan EE, et al. Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER Cohort. J Acquir Immune Defic Syndr. 2013 ;62(1):36-42.

Livelli A, Vaida F, Ellis RJ, Ma Q, Ferrara M, Clifford DB, Collier AC, Gelman B, Marra CM, McArthur JC, et al. Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort study. Lancet HIV. 2019 ;6(7):e456-e462.

Taylor MJ, Schweinsburg BC, Alhassoon OM, Gongvatana A, Brown GG, Young-Casey C, Letendre S, Grant I. Effects of human immunodeficiency virus and methamphetamine on cerebral metabolites measured with magnetic resonance spectroscopy. Journal of Neurovirology [Internet]. 2007 ;13:150-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17505983

Nguyen A, Rossi S, Croteau D, Best BM, Clifford DB, Collier AC, Gelman B, Marra C, McArthur JC, McCutchan JA, et al. Etravirine in CSF is highly protein bound. J Antimicrob Chemother. 2013 ;68(5):1161-8.

Woods SPaul, Carey C, Moran LM, Dawson MS, Letendre S, Grant I. Frequency and predictors of self-reported prospective memory complaints in individuals infected with HIV. Archives of Clinical Neuropsychology: The Official Journal of the National Academy of Neuropsychologists [Internet]. 2007 ;22:187-95. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17289343

Wagner GA, Chaillon A, Liu S, Franklin D, Caballero G, Pond SLK, Vaida F, Heaton RK, Letendre S, Grant I, et al. HIV-associated neurocognitive disorder is associated with HIV-1 dual infection. AIDS. 2016 ;30(17):2591-2597.

Fennema-Notestine C, Ellis RJ, Archibald SL, Jernigan TL, Letendre S, Notestine RJ, Taylor MJ, Theilmann RJ, Julaton MD, Croteau D, et al. Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infection. J Neurovirol. 2013 ;19(4):393-401.

Suh H-S, Lo Y, Choi N, Letendre S, Lee SC. Insulin-like growth factors and related proteins in plasma and cerebrospinal fluids of HIV-positive individuals. J Neuroinflammation. 2015 ;12:72.

Bandaru VVenkata Ra, Mielke MM, Sacktor N, McArthur JC, Grant I, Letendre S, Chang L, Wojna V, Pardo C, Calabresi P, et al. A lipid storage-like disorder contributes to cognitive decline in HIV-infected subjects. Neurology. 2013 ;81(17):1492-9.

Letendre S, Woods SPaul, Ellis RJ, Atkinson JH, Masliah E, van den Brande G, Durelle J, Grant I, Everall I. Lithium improves HIV-associated neurocognitive impairment. AIDS (London, England) [Internet]. 2006 ;20:1885-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16954730

Woods SPaul, Morgan EE, Marquie-Beck J, Carey C, Grant I, Letendre S. Markers of macrophage activation and axonal injury are associated with prospective memory in HIV-1 disease. Cognitive and Behavioral Neurology: Official Journal of the Society for Behavioral and Cognitive Neurology [Internet]. 2006 ;19:217-21. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17159619

Ubaida-Mohien C, Lamberty B, Dickens AM, Mielke MM, Marcotte TD, Sacktor N, Grant I, Letendre S, Franklin D, Cibrowski P, et al. Modifications in acute phase and complement systems predict shifts in cognitive status of HIV-infected patients. AIDS. 2017 ;31(10):1365-1378.

Desplats P, Dumaop W, Smith DM, Adame A, Everall I, Letendre S, Ellis RJ, Cherner M, Grant I, Masliah E. Molecular and pathologic insights from latent HIV-1 infection in the human brain. Neurology. 2013 ;80(15):1415-23.

Marra CM, Deutsch R, Collier AC, Morgello S, Letendre S, Clifford DB, Gelman B, McArthur JC, McCutchan JA, Simpson DM, et al. Neurocognitive impairment in HIV-infected individuals with previous syphilis. Int J STD AIDS. 2013 ;24(5):351-5.

Letendre S, Paulino A, Rockenstein E, Adame A, Crews LA, Cherner M, Heaton RK, Ellis RJ, Everall I, Grant I, et al. Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV. The Journal of Infectious Diseases [Internet]. 2007 ;196:361-70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17597450

Fazeli PL, Marquine MJ, Dufour C, Henry BL, Montoya JL, Gouaux B, Moore RC, Letendre S, Woods SPaul, Grant I, et al. Physical Activity is Associated with Better Neurocognitive and Everyday Functioning Among Older Adults with HIV Disease. AIDS Behav. 2015 ;19(8):1470-7.

Langford D, Marquie-Beck J, de Almeida SM, Lazzaretto D, Letendre S, Grant I, McCutchan JA, Masliah E, Ellis RJ. Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients. Journal of Neurovirology [Internet]. 2006 ;12:100-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16798671